Education
About Us
Working with TipRanks
Follow Us
RxSight (RXST)
NASDAQ:RXST
RXST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$24.79 - $66.54
Previous CloseN/A
Volume110.15K
Average Volume (3M)564.39K
Market Cap
$1.02B
Enterprise Value$1.74B
Total Cash (Recent Filing)$9.69M
Total Debt (Recent Filing)$3.01M
Price to Earnings (P/E)―
Beta1.18
Next Earnings
May 13, 2025EPS Estimate
-0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.71
Shares Outstanding40,490,543
10 Day Avg. Volume708,513
30 Day Avg. Volume564,394
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)7.26
Price to Cash Flow (P/CF)-59.60
P/FCF Ratio0.00
Enterprise Value/Market Cap1.71
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit32.38
Enterprise Value/Ebitda-65.78
Forecast
1Y Price Target
$43.38Price Target Upside72.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
---
RxSight News
PremiumCompany Announcements
RxSight, Inc. Reports Strong Revenue Growth Amid Challenges
PremiumCompany Announcements
RxSight, Inc. Reports Strong 2024 Financial Growth---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRXST's 3-year revenue CAGR stands at approximately 30%, significantly higher than peers at around 17%, indicating strong growth potential.
Market PositionRXST holds over 10% share in the premium market, indicating strong market presence.
Bears Say
Stock PerformanceRXST's stock has been having a tough time, with worries around LDD placements giving way to worries about utilization and disruption from competitive launches.
---
Ownership Overview
4.88% Insiders
20.10% Mutual Funds
33.11% Other Institutional Investors
27.08% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RXST FAQ
What was RxSight’s price range in the past 12 months?
RxSight lowest stock price was $24.79 and its highest was $66.54 in the past 12 months.
What is RxSight’s market cap?
RxSight’s market cap is $1.02B.
When is RxSight’s upcoming earnings report date?
RxSight’s upcoming earnings report date is May 13, 2025 which is in 63 days.
How were RxSight’s earnings last quarter?
RxSight released its earnings results on Feb 25, 2025. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.166 by $0.016.
Is RxSight overvalued?
According to Wall Street analysts RxSight’s price is currently Undervalued.
Does RxSight pay dividends?
RxSight does not currently pay dividends.
What is RxSight’s EPS estimate?
RxSight’s EPS estimate is -0.2.
How many shares outstanding does RxSight have?
RxSight has 40,490,543 shares outstanding.
What happened to RxSight’s price movement after its last earnings report?
RxSight reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.166. Following the earnings report the stock price went down -0.822%.
Which hedge fund is a major shareholder of RxSight?
Currently, no hedge funds are holding shares in RXST
---
RxSight Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$43.38 (72.83% Upside)
$43.38 (72.83% Upside)
Blogger Sentiment
Bullish
RXST Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 845.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $100.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-53.39%
12-Months-Change
Fundamentals
Return on Equity
-12.43%
Trailing 12-Months
Asset Growth
74.51%
Trailing 12-Months
Company Description
RxSight
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.
---
RXST Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant revenue growth, gross margin expansion, and positive adjusted net income. However, the company continues to face net losses and increased operating expenses. The introduction of new product features and FDA approvals positions the company well for future growth.Read More>---
RXST Stock 12 Month Forecast
Average Price Target
$43.38
▲(72.83% Upside)
Technical Analysis
Align Tech
―
Cooper Co
―
Staar Surgical
―
Zimmer Biomet Holdings
―
National Vision Holdings
―
Best Analysts Covering RXST
1 Year
1 Year Success Rate
13/22 ratings generated profit
1 Year Average Return
+61.07%
reiterated a buy rating 13 days ago
Copying David Saxon's trades and holding each position for 1 Year would result in 59.09% of your transactions generating a profit, with an average return of +61.07% per trade.
---